161 related articles for article (PubMed ID: 36009668)
1. Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function.
Suzuki R; Yuchi Y; Saito T; Yasumura Y; Teshima T; Matsumoto H; Koyama H
Animals (Basel); 2022 Aug; 12(16):. PubMed ID: 36009668
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension.
Suzuki R; Yuchi Y; Saito T; Teshima T; Matsumoto H; Koyama H
Front Vet Sci; 2022; 9():876178. PubMed ID: 35498754
[TBL] [Abstract][Full Text] [Related]
3. Comparative Study of Cardiovascular Effects of Selected Pulmonary Vasodilators in Canine Models of Mitral Valve Disease.
Yuchi Y; Suzuki R; Ishida N; Satomi S; Saito T; Teshima T; Matsumoto H
Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785793
[TBL] [Abstract][Full Text] [Related]
4. Associations of 2D speckle tracking echocardiography-based right heart deformation parameters and invasively assessed hemodynamic measurements in patients with pulmonary hypertension.
Theres L; Hübscher A; Stangl K; Dreger H; Knebel F; Brand A; Hewing B
Cardiovasc Ultrasound; 2020 May; 18(1):13. PubMed ID: 32410698
[TBL] [Abstract][Full Text] [Related]
5. A combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats.
Ueno M; Miyauchi T; Sakai S; Yamauchi-Kohno R; Goto K; Yamaguchi I
J Am Coll Cardiol; 2002 Jul; 40(1):175-81. PubMed ID: 12103273
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension.
Ono F; Nagaya N; Kyotani S; Oya H; Nakanishi N; Miyatake K
Circ J; 2003 May; 67(5):375-8. PubMed ID: 12736472
[TBL] [Abstract][Full Text] [Related]
7. Right ventricular systolic and diastolic function assessed by two-dimensional speckle tracking echocardiography in dogs with myxomatous mitral valve disease.
Yuchi Y; Suzuki R; Teshima T; Matsumoto H; Koyama H
J Vet Med Sci; 2021 Dec; 83(12):1918-1927. PubMed ID: 34732606
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Effect of Epoprostenol and Intravenous Cardiac Drugs for Acute Heart Failure on Canine Pulmonary Hypertension.
Yuchi Y; Suzuki R; Satomi S; Saito T; Teshima T; Matsumoto H
Vet Sci; 2023 Apr; 10(4):. PubMed ID: 37104457
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term administration of a prostacyclin analogue (beraprost sodium) on myocardial fibrosis in Dahl rats.
Kaneshige T; Saida Y; Tanaka R; Soda A; Fukushima A; Ida N; Takenaka M; Yamane Y
J Vet Med Sci; 2007 Dec; 69(12):1271-6. PubMed ID: 18176024
[TBL] [Abstract][Full Text] [Related]
10. [Effect of long-term therapy with oral Beraprost on survival of patients with arterial and inoperable thromboembolic pulmonary hypertension].
Kurzyna M; Florczyk M; Fijałkowska A; Kuca P; Szewczyk G; Burakowski J; Kober J; Sikora J; Wawrzyńska L; Szturmowicz M; Tomkowskil W; Torbicki A
Pol Arch Med Wewn; 2004 Apr; 111(4):477-82. PubMed ID: 15517762
[TBL] [Abstract][Full Text] [Related]
11. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major vessel obstruction.
Ono F; Nagaya N; Okumura H; Shimizu Y; Kyotani S; Nakanishi N; Miyatake K
Chest; 2003 May; 123(5):1583-8. PubMed ID: 12740277
[TBL] [Abstract][Full Text] [Related]
12. [Combination of oral endothelin-A receptor antagonist and oral prostacyclin analogue is superior to each drug alone in ameliorating pulmonary hypertension in rats].
Ueno M; Miyauchi T; Sakai S; Yamauchi-Kohno R; Goto K; Yamaguchi I
J Cardiol; 2003 Jan; 41(1):45-6. PubMed ID: 12564116
[TBL] [Abstract][Full Text] [Related]
13. The additive value of echocardiographic pulmonary to left atrial global strain ratio in the diagnosis of pulmonary hypertension.
Venkateshvaran A; Manouras A; Kjellström B; Lund LH
Int J Cardiol; 2019 Oct; 292():205-210. PubMed ID: 31176524
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease.
Durongpisitkul K; Laoprasitiporn D; Layangool T; Sittiwankul R; Panamonta M; Mokrapong P;
Circ J; 2005 Jan; 69(1):61-4. PubMed ID: 15635204
[TBL] [Abstract][Full Text] [Related]
15. Effect of beraprost sodium on pulmonary vascular resistance in candidates for a Fontan procedure: a preliminary study.
Takahashi K; Mori Y; Yamamura H; Nakanishi T; Nakazawa M
Pediatr Int; 2003 Dec; 45(6):671-5. PubMed ID: 14651539
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-A-receptor antagonist and oral prostacyclin analog are comparably effective in ameliorating pulmonary hypertension and right ventricular hypertrophy in rats.
Ueno M; Miyauchi T; Sakai S; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S305-10. PubMed ID: 11078405
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Vascular Resistance Estimated by Echocardiography in Dogs With Myxomatous Mitral Valve Disease and Pulmonary Hypertension Probability.
Suzuki R; Yuchi Y; Kanno H; Saito T; Teshima T; Matsumoto H; Koyama H
Front Vet Sci; 2021; 8():771726. PubMed ID: 34765671
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension.
Olsson KM; Frank A; Fuge J; Welte T; Hoeper MM; Bitter T
Respir Res; 2015 Nov; 16():137. PubMed ID: 26538143
[TBL] [Abstract][Full Text] [Related]
19. Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension.
Jenei C; Kádár R; Balogh L; Borbély A; Győry F; Péter A; Daragó A; Csanádi Z
ESC Heart Fail; 2021 Oct; 8(5):3975-3983. PubMed ID: 34184427
[TBL] [Abstract][Full Text] [Related]
20. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T
J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
